Finalization of Draft Rules on Sale of Drugs by E-Pharmacies in India

0
328
Drugs Sales
Drugs Sales

Finalization of Draft Rules on Sale of Drugs by E-Pharmacies

By PIB Delhi

The Government has published draft rules vide G.S.R. 817 (E) dated 28th August 2018 for inviting public/stakeholder comments for an amendment to the Drugs and Cosmetics Rules, 1945 for incorporating provisions relating to the regulation of sale and distribution of drugs through e-pharmacy. A large number of suggestions/ comments have been received from the stakeholders, which are being examined. At the same time, the matter is subjudice before various Hon’ble High Courts in the country. Therefore, no timeline for finalization of the rules can be provided.

Under the Drugs & Cosmetics Act and Rules, sale of spurious drugs is a punishable offense and State Licensing Authorities are empowered to take action in this regard. Accordingly, the complaints as received, are referred to State Licensing Authorities for taking action as per the provisions of the Act and Rules.

The Minister of State (Health and Family Welfare), Shri Ashwini Kumar Choubey stated this in a written reply in the Rajya Sabha here today.